DREW/MEHARRY/MOREHOUSE CONSORTIUM CANCER CENTER

这项提议寻求五年的核心资金，以继续研究 德鲁-梅哈里-莫尔豪斯联盟癌症中心(联盟癌症 居中)。基金将支持高级领导层、项目主任、 行政、规划和评价，3个共享资源(环境统计， 临床试验，以及乳腺细胞培养和组织库)，以及一个 翻译和职业研究的发展计划。 财团癌症中心的长期目标是 降低美国黑人癌症的高发病率和死亡率 人口。这一目标是通过调动智力资源来实现的 将三所私立历史上的黑人医学院合并为一所 针对癌症预防和控制的合作研究努力。 一般的研究策略一直是专注于翻译 研究、传播旨在告知和鼓励信息的信息 向更健康的生活方式和更好的健康寻求的行为改变 行为，除了提高黑人在州立大学的入学率 通过合作组临床试验进行抗癌药物治疗。这将是 继续是中心的总体战略，但重组 需要其研究计划的一部分，以促进纳入新的Basic 以及参与该联盟研究项目的行为科学家 癌症中心。加强研究力度将是新的发展 用于定义致病因素和风险因素的信息 癌症发病率和死亡率的种族差异，以便 继续推进癌症防控工作。中的当前计划 一级预防和二级预防将沿着以下方向进行重组 项目：1.乳腺癌研究；2.翻译研究 重点关注信息和行为变化，以及3.流行病学， 病因学研究计划。

This proposal seeks core funding for five years to continue the research of the Drew-Meharry-Morehouse Consortium Cancer Center (Consortium Cancer Center). Funds will support senior leadership, program directors, administration, planning and evaluation, 3 shared resources (epi-stat, clinical trials, and a breast cell culture and tissue bank), and one developmental program in translational and occupational research. The broad long term objective of the Consortium Cancer Center is to reduce the high incidence and mortality for cancer in the U. S. black population. This goal is pursued by mobilizing the intellectual resources of the three private historically black medical schools into a collaborative research effort directed at cancer prevention and control. The general research strategy has been to focus on translational research, diffusion of information intended to inform and encourage behavioral change to healthier life styles and improved health seeking behavior, in addition to enhanced enrollment of blacks in state-of-the- art cancer treatment via cooperative group clinical trials. This will continue to be the overall strategy of the Center however restructuring of its research programs is needed to facilitate inclusion of new basic and behavioral scientists in the research programs of the Consortium Cancer Center. Enhancing the research effort will be development of new information for defining etiological and risk factors contributing to ethnic differences in cancer incidence and mortality, in order to continue progress in cancer prevention and control. Current programs in primary and secondary prevention will be restructured along the following programs: 1. breast cancer research; 2. translational research which focuses on information and behavioral change, and 3. epidemiology, etiology research program.